We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Says Cause of ‘Unexplained Illness’ in Phase 3 Vaccine Trial Hasn’t Been Confirmed
AstraZeneca Says Cause of ‘Unexplained Illness’ in Phase 3 Vaccine Trial Hasn’t Been Confirmed
Reports “are incorrect” that a participant in AstraZeneca’s COVID-19 vaccine trial that was paused Tuesday suffered from transverse myelitis, an AstraZeneca spokesperson told FDAnews Wednesday.